• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report.

作者信息

Schuurkamp G J, Spicer P E, Kereu R K, Bulungol P K

机构信息

Medical Department, Ok Tedi Mining Limited, Tabubil, Western Province, Papua, New Guinea.

出版信息

Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):607-8. doi: 10.1016/0035-9203(89)90370-2.

DOI:10.1016/0035-9203(89)90370-2
PMID:2694500
Abstract
摘要

相似文献

1
A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report.间日疟和恶性疟的混合感染，对4-氨基喹啉明显耐药：病例报告
Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):607-8. doi: 10.1016/0035-9203(89)90370-2.
2
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.巴布亚新几内亚针对恶性疟原虫、间日疟原虫和三日疟原虫的标准治疗方案的寄生虫学及临床疗效
P N G Med J. 2005 Sep-Dec;48(3-4):141-50.
3
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.在巴布亚新几内亚，阿莫地喹或氯喹联合磺胺多辛-乙胺嘧啶治疗恶性疟原虫和间日疟原虫疟疾的疗效较低。
Am J Trop Med Hyg. 2007 Nov;77(5):947-54.
4
Evaluation of amodiaquine treatment of chloroquine-resistant Plasmodium falciparum malaria on Zanzibar, 1982.1982年在桑给巴尔对阿莫地喹治疗氯喹耐药恶性疟原虫疟疾的评估。
Am J Trop Med Hyg. 1983 Nov;32(6):1216-20. doi: 10.4269/ajtmh.1983.32.1216.
5
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.1990 - 1993年巴布亚新几内亚马当省恶性疟原虫疟疾对阿莫地喹、氯喹和奎宁的耐药性
P N G Med J. 1996 Mar;39(1):16-22.
6
Chloroquine resistant Plasmodium falciparum malaria in East New Britain, Papua New Guinea.巴布亚新几内亚东新不列颠省的氯喹抗性恶性疟原虫疟疾
P N G Med J. 1980 Sep;23(3):117-25.
7
[In vivo and in vitro study of the chemosensitivity of Plasmodium falciparum in Madagascar--1982-1986].[1982 - 1986年马达加斯加恶性疟原虫化学敏感性的体内和体外研究]
Arch Inst Pasteur Madagascar. 1987;53(1):63-76.
8
Chloroquine and amodiaquine resistant falciparum malaria in Rwanda.
Lancet. 1985 Nov 9;2(8463):1072. doi: 10.1016/s0140-6736(85)90944-4.
9
[Evaluation of Plasmodium falciparum susceptibility to chloroquine and amodiaquine using a simplified, in vivo, 7-day test in southern Cameroon].[在喀麦隆南部使用简化的体内7天试验评估恶性疟原虫对氯喹和氨酚喹的敏感性]
Med Trop (Mars). 1990 Jan-Mar;50(1):27-31.
10
[Drug sensitivity of malaria in Madagascar. Comparison in vivo and in vitro of the effects of chloroquine and amodiaquine on P. falciparum in 1984].
Arch Inst Pasteur Madagascar. 1986;52(1):73-84.

引用本文的文献

1
Analysis of Plasmodium vivax Chloroquine Resistance Transporter Mutant Isoforms.间日疟原虫氯喹抗性转运蛋白突变异构体分析
Biochemistry. 2017 Oct 17;56(41):5615-5622. doi: 10.1021/acs.biochem.7b00749. Epub 2017 Sep 26.
2
Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.泰国-缅甸边境间日疟原虫感染患者三日氯喹治疗的群体药代动力学
Malar J. 2016 Feb 29;15:129. doi: 10.1186/s12936-016-1181-1.
3
Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.
巴布亚新几内亚两个地区与恶性疟原虫和间日疟原虫耐药性相关的突变流行率存在显著地理差异。
Malar J. 2015 Oct 9;14:399. doi: 10.1186/s12936-015-0879-9.
4
Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.越南中部确诊间日疟原虫对氯喹耐药
Antimicrob Agents Chemother. 2015 Dec;59(12):7411-9. doi: 10.1128/AAC.00791-15. Epub 2015 Sep 21.
5
Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.2009-2010 年泰缅边境地区间日疟原虫对氯喹的临床疗效和体外敏感性监测。
Malar J. 2011 Feb 16;10:44. doi: 10.1186/1475-2875-10-44.
6
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.阿莫地喹单药疗法治疗氯喹耐药间日疟原虫感染的体内和体外疗效
Antimicrob Agents Chemother. 2009 Mar;53(3):1094-9. doi: 10.1128/AAC.01511-08. Epub 2008 Dec 22.
7
In vitro drug sensitivity testing in Plasmodium vivax.间日疟原虫的体外药敏试验
Wien Klin Wochenschr. 2008;120(19-20 Suppl 4):30-3. doi: 10.1007/s00508-008-1030-5.
8
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.泰国西北部地区间日疟原虫对氯喹、甲氟喹和青蒿素的敏感性。
Wien Klin Wochenschr. 2007;119(19-20 Suppl 3):76-82. doi: 10.1007/s00508-007-0872-6.
9
The evolution of tafenoquine--antimalarial for a new millennium?他非诺喹的演变——面向新千年的抗疟药？
J R Soc Med. 1999 Jul;92(7):345-52. doi: 10.1177/014107689909200705.
10
The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.氯喹在健康泰国受试者和间日疟原虫疟疾患者中的药代动力学。
Br J Clin Pharmacol. 1994 Sep;38(3):278-81. doi: 10.1111/j.1365-2125.1994.tb04354.x.